TAYLOR KRAWCZYK: Open Payments
NPI 1457193393 · NEW HYDE PARK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$824 in 51 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $154 · 2025 $824
Food & beverage: $769Education: $55
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 26 | $277 |
| Ferring Pharmaceuticals Inc. | 9 | $150 |
| Janssen Biotech, Inc. | 7 | $150 |
| SEAGEN INC. | 1 | $55 |
| TOLMAR, INC. | 2 | $54 |
| Verity Pharmaceuticals Inc. | 2 | $38 |
| UROGEN PHARMA, INC. | 1 | $31 |
| Olympus America Inc. | 1 | $30 |
| Myriad Genetic Laboratories, Inc. | 1 | $22 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $16 |
Products named: GEMTESA, ADSTILADRIN, ERLEADA, ORGOVYX, JATENZO, Trelstar, JELMYTO, iTIND System.
Industry payments across NY — which companies pay providers there.
